U.S. markets closed

Neoleukin: 4Q Earnings Snapshot

SEATTLE (AP) _ Neoleukin Therapeutics, Inc. (NLTX) on Thursday reported a loss of $8.1 million in its fourth quarter.

On a per-share basis, the Seattle-based company said it had a loss of 23 cents.

For the year, the company reported that its loss widened to $69.4 million, or $2.57 per share.

Neoleukin shares have declined 39% since the beginning of the year. In the final minutes of trading on Thursday, shares hit $7.53, nearly tripling in the last 12 months.


This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on NLTX at https://www.zacks.com/ap/NLTX